Free Trial

ImageneBio (IMA) Earnings Date, Estimates & Call Transcripts

ImageneBio logo
$16.97 +1.68 (+10.99%)
As of 11:30 AM Eastern

ImageneBio Earnings Summary

ImageneBio issued Q2 2025 earnings on July 24, 2025, reporting an EPS of -$0.06, which topped analysts' consensus estimates of -$0.14 by $0.08. With a trailing EPS of $0.21, ImageneBio's earnings are expected to grow next year, from ($0.91) to ($0.82) per share.

Upcoming Q3
Earnings Date
Aug. 14Before Market OpensEstimated
Consensus EPS
(Jul. 24)
-$0.14
Actual EPS
(Jul. 24)
-$0.06 Beat By $0.08

Q2 2025 Earnings Resources

IMA Upcoming Earnings

ImageneBio's Q2 2025 earnings is scheduled for Thursday, August 14, 2025

Get ImageneBio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ImageneBio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IMA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IMA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ImageneBio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$2.40-$2.16-$2.28
Q2 20252-$2.40-$1.80-$2.10
Q3 20252-$2.40-$1.68-$2.04
Q4 20252-$2.40-$1.68-$2.04
FY 2025 8 -$9.60 -$7.32 -$8.46
Q1 20261-$2.40-$2.40-$2.40
Q2 20261-$2.16-$2.16-$2.16
Q3 20261-$2.16-$2.16-$2.16
Q4 20261-$2.28-$2.28-$2.28

ImageneBio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025
(Estimated)
--------
7/24/2025Q2 2025-$0.14-$0.06+$0.08-$0.06--
5/8/2025Q1 2025-$2.52-$2.16+$0.36-$0.18--
3/11/2025Q4 2024-$2.76-$2.16+$0.60-$0.19--
11/7/2024Q3 2024-$3.24-$2.28+$0.96-$0.17--
8/8/2024Q2 2024-$3.72-$3.24+$0.48-$0.26--
5/13/2024Q1 2024-$4.80-$3.36+$1.44-$0.23--
3/12/2024Q4 2023-$4.92-$4.92--$0.41$2.39M$0.66M
11/9/2023Q3 2023-$5.28-$4.80+$0.48-$0.40--
8/10/2023Q2 2023-$5.76-$5.28+$0.48-$0.44$3.63M$2.00M

Ikena Oncology Earnings - Frequently Asked Questions

Ikena Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on IMA's earnings history.

In the previous quarter, Ikena Oncology (NASDAQ:IMA) reported ($0.06) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.08. Learn more on analysts' earnings estimate vs. IMA's actual earnings.

Ikena Oncology (NASDAQ:IMA) has a recorded annual revenue of $9.16 million.

Ikena Oncology (NASDAQ:IMA) has a recorded net income of -$49.23 million. IMA has generated $0.21 earnings per share over the last four quarters.

Ikena Oncology's earnings are expected to grow from ($0.91) per share to ($0.82) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:IMA) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners